LLY · Eli Lilly and Co.
AI read · Good for LLY
The AI's read
This gives Lilly another group of patients who may receive Jaypirca earlier in their treatment. The study found responses in 94% of patients, and the comparison group's median time before disease worsened was 33.5 months; Jaypirca's had not yet been reached. The approval applies only to adults without a known 17p deletion. The story gives no sales estimate or safety findings, but the approval and study results make this positive for Lilly.